WS Investor
04 Mar 2026, 14:44
Veeva Systems Inc. (NYSE: VEEV) announced that more than 125 customers worldwide are now live on its next-generation Vault CRM platform, marking growing adoption of its AI-enabled customer relationship management system for the life sciences industry.
The customers include several top 20 biopharmaceutical companies as well as organizations across the United States, Europe, and Japan. Vault CRM is designed to support commercial and medical teams throughout the full product lifecycle, from product launch preparation to the management of mature brands.
The platform forms part of the Vault CRM Suite, which also includes applications such as Events Management, Service Center, Campaign Manager, and Patient CRM. Veeva said the system combines industry-specific workflows, compliance features, and AI capabilities to support complex customer engagement across global biopharma markets.
Following the increasing adoption of Vault CRM, the company also updated the end-of-support timeline for its legacy Veeva CRM platform, moving the date from September 2030 to the end of December 2029.
PRNewswire
The customers include several top 20 biopharmaceutical companies as well as organizations across the United States, Europe, and Japan. Vault CRM is designed to support commercial and medical teams throughout the full product lifecycle, from product launch preparation to the management of mature brands.
The platform forms part of the Vault CRM Suite, which also includes applications such as Events Management, Service Center, Campaign Manager, and Patient CRM. Veeva said the system combines industry-specific workflows, compliance features, and AI capabilities to support complex customer engagement across global biopharma markets.
Following the increasing adoption of Vault CRM, the company also updated the end-of-support timeline for its legacy Veeva CRM platform, moving the date from September 2030 to the end of December 2029.
PRNewswire